Cargando…
Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells
BACKGROUND: Monoclonal antibodies targeting programmed death-1 receptor (PD-1) and its ligand (PD-L1) have been developed to treat cancers including lung cancer. In this study, we aimed to investigate whether lycopene could promote the effect of anti-PD-1 treatment on lung cancer. METHODS: Tumor for...
Autores principales: | Jiang, Xiufeng, Wu, Hui, Zhao, Wei, Ding, Xiao, You, Qian, Zhu, Feng, Qian, Meifang, Yu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429703/ https://www.ncbi.nlm.nih.gov/pubmed/30948928 http://dx.doi.org/10.1186/s12935-019-0789-y |
Ejemplares similares
-
Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines
por: Teodoro, Anderson Junger, et al.
Publicado: (2012) -
Adipocytes promote tumor progression and induce PD-L1 expression via TNF-α/IL-6 signaling
por: Li, Zhi, et al.
Publicado: (2020) -
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
por: Gao, Zheng, et al.
Publicado: (2022) -
Serum-derived exosomes promote CD8+ T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma
por: Gao, Qian, et al.
Publicado: (2021) -
SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019)